Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Larimar Therapeutics Debt Issuance/Retirement Net - Total 2012-2025 | LRMR

Larimar Therapeutics debt issuance/retirement net - total from 2012 to 2025. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
  
Larimar Therapeutics Annual Debt Issuance/Retirement Net - Total
(Millions of US $)
2024 $N/A
2023 $N/A
2022 $N/A
2021 $N/A
2020 $N/A
2019 $N/A
2018 $N/A
2017 $16
2016 $-3
2015 $-1
2014 $7
2013 $N/A
2012 $6
2011 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.305B $0.000B
Larimar Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing treatments for rare diseases. The company's lead product consist CTI-1601, which is in clinical stage. Larimar Therapeutics Inc., formerly known as Zafgen Inc., is based in BALA CYNWYD, Pa.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $69.638B 26.78
Zoetis (ZTS) United States $68.964B 25.02
Takeda Pharmaceutical (TAK) Japan $48.715B 9.94
Daiichi Sankyo, - (DSNKY) Japan $47.927B 24.56
BeOne Medicines - (ONC) Switzerland $34.411B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.721B 0.00
Summit Therapeutics (SMMT) United States $19.321B 0.00
Merck (MKKGY) Germany $16.724B 10.87
Shionogi (SGIOY) Japan $14.853B 14.88
United Therapeutics (UTHR) United States $14.013B 12.13
Neurocrine Biosciences (NBIX) United States $13.417B 40.02
IPSEN (IPSEY) France $11.320B 0.00
Orion OYJ (ORINY) Finland $11.248B 27.11
Eisai (ESAIY) $9.064B 10.22
Madrigal Pharmaceuticals (MDGL) United States $9.039B 0.00
Corcept Therapeutics (CORT) United States $7.479B 62.81
Grifols, S.A (GRFS) Spain $6.931B 0.00
Stevanato Group S.p.A (STVN) Italy $6.920B 40.80
Ionis Pharmaceuticals (IONS) United States $6.891B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Soleno Therapeutics (SLNO) United States $3.710B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.225B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.993B 14.22
Crinetics Pharmaceuticals (CRNX) United States $2.769B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.753B 0.00
Hypermarcas (HYPMY) Brazil $2.692B 20.24
Catalyst Pharmaceuticals (CPRX) United States $2.516B 8.43
Centessa Pharmaceuticals (CNTA) United Kingdom $2.348B 0.00
Ocular Therapeutix (OCUL) United States $2.111B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.759B 0.00
Dyne Therapeutics (DYN) United States $1.738B 0.00
Guardian Pharmacy Services (GRDN) United States $1.665B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.590B 23.69
Ardelyx (ARDX) United States $1.472B 0.00
ARS Pharmaceuticals (SPRY) United States $1.470B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.439B 0.00
Harrow (HROW) United States $1.412B 0.00
Evotec AG (EVO) Germany $1.257B 0.00
Collegium Pharmaceutical (COLL) United States $1.245B 6.80
Xeris Biopharma Holdings (XERS) United States $1.226B 0.00
Enliven Therapeutics (ELVN) United States $1.175B 0.00
Cronos Group (CRON) Canada $0.981B 0.00
Akebia Therapeutics (AKBA) United States $0.846B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.753B 7.76
Amylyx Pharmaceuticals (AMLX) United States $0.752B 0.00
Theravance Biopharma (TBPH) United States $0.688B 56.92
ProKidney (PROK) United States $0.679B 0.00
KalVista Pharmaceuticals (KALV) United States $0.647B 0.00
Siga Technologies (SIGA) United States $0.627B 7.74
Elite Pharmaceuticals (ELTP) United States $0.594B 0.00
Tourmaline Bio (TRML) United States $0.592B 0.00
Relay Therapeutics (RLAY) United States $0.588B 0.00
Bioventus (BVS) United States $0.585B 14.16
Organogenesis (ORGO) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.560B 11.47
Oruka Therapeutics (ORKA) United States $0.554B 0.00
Zevra Therapeutics (ZVRA) United States $0.534B 0.00
Nektar Therapeutics (NKTR) United States $0.533B 0.00
Xencor (XNCR) United States $0.531B 0.00
Savara (SVRA) United States $0.527B 0.00
Nanobiotix S.A (NBTX) France $0.467B 0.00
Esperion Therapeutics (ESPR) United States $0.429B 0.00
Aquestive Therapeutics (AQST) United States $0.390B 0.00
Aldeyra Therapeutics (ALDX) United States $0.352B 0.00
4D Molecular Therapeutics (FDMT) United States $0.320B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.314B 0.00
Altimmune (ALT) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.293B 19.13
AleAnna (ANNA) United States $0.281B 0.00
Lexeo Therapeutics (LXEO) United States $0.258B 0.00
Galectin Therapeutics (GALT) United States $0.249B 0.00
OmniAb (OABI) United States $0.221B 0.00
Lyell Immunopharma (LYEL) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
Korro Bio (KRRO) United States $0.193B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.191B 29.50
Aclaris Therapeutics (ACRS) United States $0.190B 0.00
MediWound (MDWD) Israel $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.182B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.165B 0.00
MEI Pharma (MEIP) United States $0.150B 0.00
Achieve Life Sciences (ACHV) Canada $0.148B 0.00
Profound Medical (PROF) Canada $0.138B 0.00
Avita Medical (RCEL) United States $0.126B 0.00
Inhibikase Therapeutics (IKT) United States $0.125B 0.00
Avalo Therapeutics (AVTX) United States $0.123B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.119B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Champions Oncology (CSBR) United States $0.102B 23.16
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Surrozen (SRZN) United States $0.097B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
VAXART, INC (VXRT) United States $0.082B 0.00
Context Therapeutics (CNTX) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Liminatus Pharma (LIMN) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Metagenomi (MGX) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.065B 0.00
Wellgistics Health (WGRX) United States $0.064B 0.00
Prelude Therapeutics (PRLD) United States $0.062B 0.00
Inotiv (NOTV) United States $0.060B 0.00
DURECT (DRRX) United States $0.059B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
Jupiter Neurosciences (JUNS) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 29.45
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Plus Therapeutics (PSTV) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Klotho Neurosciences (KLTO) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
Aptorum Group (APM) United Kingdom $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Mangoceuticals (MGRX) United States $0.017B 0.00
Scienture Holdings (SCNX) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Incannex Healthcare (IXHL) Australia $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Carisma Therapeutics (CARM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
CDT Equity (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.51
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.63
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00